JMI Hospital Requisite Manufacturing Limited (DSE:JHRML)
Bangladesh
· Delayed Price · Currency is BDT 42.90
-0.80 (-1.83%)
At close: Dec 4, 2025
DSE:JHRML Income Statement
Financials in millions BDT. Fiscal year is July - June.
Millions BDT. Fiscal year is Jul - Jun.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2019 - 2020 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 | 2019 - 2020 |
| Revenue | 1,602 | 1,671 | 1,870 | 1,852 | 1,802 | 1,731 | Upgrade
|
| Revenue Growth (YoY) | -14.63% | -10.65% | 0.98% | 2.79% | 4.10% | 15.54% | Upgrade
|
| Cost of Revenue | 1,112 | 1,154 | 1,292 | 1,273 | 1,238 | 1,111 | Upgrade
|
| Gross Profit | 490.32 | 516.83 | 578.24 | 578.58 | 564.29 | 619.43 | Upgrade
|
| Selling, General & Admin | 173.61 | 149.41 | 152.34 | 145.16 | 134.28 | 127.45 | Upgrade
|
| Other Operating Expenses | 0.52 | 0.63 | 0.9 | 0.59 | 0.44 | 0.39 | Upgrade
|
| Operating Expenses | 174.13 | 150.05 | 153.23 | 145.75 | 134.73 | 127.85 | Upgrade
|
| Operating Income | 316.19 | 366.78 | 425.01 | 432.82 | 429.57 | 491.58 | Upgrade
|
| Interest Expense | -44.73 | -55.3 | -70.75 | -73.34 | -99.28 | -112.18 | Upgrade
|
| Interest & Investment Income | 1.13 | 2.23 | 8.54 | 14.21 | 7.02 | 0.94 | Upgrade
|
| Currency Exchange Gain (Loss) | 0.04 | 0.04 | 0.51 | - | - | -0.14 | Upgrade
|
| Other Non Operating Income (Expenses) | 3.9 | 3.9 | 3.37 | 3.3 | 3.3 | 2.41 | Upgrade
|
| EBT Excluding Unusual Items | 276.54 | 317.65 | 366.68 | 376.99 | 340.61 | 382.62 | Upgrade
|
| Pretax Income | 276.54 | 317.65 | 366.68 | 376.99 | 340.61 | 382.62 | Upgrade
|
| Income Tax Expense | 82.66 | 84.53 | 73.57 | 74.7 | 15.59 | 157.61 | Upgrade
|
| Earnings From Continuing Operations | 193.88 | 233.13 | 293.11 | 302.29 | 325.02 | 225 | Upgrade
|
| Minority Interest in Earnings | 6.98 | 0.05 | 0.02 | - | - | - | Upgrade
|
| Net Income | 200.86 | 233.18 | 293.13 | 302.29 | 325.02 | 225 | Upgrade
|
| Net Income to Common | 200.86 | 233.18 | 293.13 | 302.29 | 325.02 | 225 | Upgrade
|
| Net Income Growth | -31.58% | -20.45% | -3.03% | -7.00% | 44.45% | 3.49% | Upgrade
|
| Shares Outstanding (Basic) | 125 | 125 | 125 | 125 | 100 | 90 | Upgrade
|
| Shares Outstanding (Diluted) | 125 | 125 | 125 | 125 | 100 | 90 | Upgrade
|
| Shares Change (YoY) | - | - | - | 25.35% | 11.07% | - | Upgrade
|
| EPS (Basic) | 1.60 | 1.86 | 2.34 | 2.41 | 3.25 | 2.50 | Upgrade
|
| EPS (Diluted) | 1.60 | 1.86 | 2.34 | 2.41 | 3.25 | 2.50 | Upgrade
|
| EPS Growth | -31.58% | -20.45% | -3.03% | -25.80% | 30.06% | 3.49% | Upgrade
|
| Free Cash Flow | -29.11 | -97.81 | 124.11 | 117.67 | 243.49 | 43.83 | Upgrade
|
| Free Cash Flow Per Share | -0.23 | -0.78 | 0.99 | 0.94 | 2.44 | 0.49 | Upgrade
|
| Dividend Per Share | 0.500 | 0.500 | 1.000 | 0.500 | 1.250 | - | Upgrade
|
| Dividend Growth | -50.00% | -50.00% | 100.00% | -60.00% | - | - | Upgrade
|
| Gross Margin | 30.61% | 30.93% | 30.92% | 31.24% | 31.32% | 35.79% | Upgrade
|
| Operating Margin | 19.74% | 21.95% | 22.73% | 23.37% | 23.84% | 28.40% | Upgrade
|
| Profit Margin | 12.54% | 13.96% | 15.67% | 16.32% | 18.04% | 13.00% | Upgrade
|
| Free Cash Flow Margin | -1.82% | -5.85% | 6.64% | 6.35% | 13.51% | 2.53% | Upgrade
|
| EBITDA | 454.2 | 507.06 | 570.48 | 587.04 | 594.37 | 673.16 | Upgrade
|
| EBITDA Margin | 28.36% | 30.35% | 30.50% | 31.70% | 32.99% | 38.89% | Upgrade
|
| D&A For EBITDA | 138.01 | 140.28 | 145.47 | 154.22 | 164.8 | 181.58 | Upgrade
|
| EBIT | 316.19 | 366.78 | 425.01 | 432.82 | 429.57 | 491.58 | Upgrade
|
| EBIT Margin | 19.74% | 21.95% | 22.73% | 23.37% | 23.84% | 28.40% | Upgrade
|
| Effective Tax Rate | 29.89% | 26.61% | 20.06% | 19.82% | 4.58% | 41.19% | Upgrade
|
| Advertising Expenses | - | 7.2 | 9.39 | 9.82 | 8.57 | 6.29 | Upgrade
|
Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.